Mylan Pharmaceuticals Inc. drugs

26 results

  • Armodafinil (armodafinil)

    (armodafinil)
    Mylan Pharmaceuticals Inc.
    Usage: Armodafinil tablets are indicated for improving wakefulness in adults with excessive sleepiness due to obstructive sleep apnea, narcolepsy, or shift work disorder. It treats excessive sleepiness in OSA but is not a treatment for the underlying condition. CPAP therapy should be prioritized before starting armodafinil.

  • Baclofen (baclofen)

    (Baclofen)
    Mylan Pharmaceuticals Inc.
    Usage: Baclofen Injection is indicated for managing severe spasticity, particularly in patients with spinal cord injuries or cerebral palsy, who have not responded to oral baclofen. It is used intrathecally via a screening dose and long-term through FDA-approved implantable pumps, following positive initial responses.

  • Bepotastine besilate (bepotastine besilate)

    (Bepotastine Besilate)
    Mylan Pharmaceuticals Inc.
    Usage: Bepotastine besilate ophthalmic solution, 1.5% is indicated for treating itching associated with allergic conjunctivitis symptoms.

  • Buspirone hydrochloride (buspirone hydrochloride)

    (buspirone hydrochloride)
    Mylan Pharmaceuticals Inc.
    Usage: Buspirone hydrochloride tablets are indicated for managing anxiety disorders, particularly Generalized Anxiety Disorder (GAD), and for short-term relief of anxiety symptoms. It can also relieve anxiety in patients with coexisting depressive symptoms. Long-term efficacy beyond 3-4 weeks is not established, although short-term use is supported by studies.

  • Candesartan cilexetil (candesartan cilexetil)

    (candesartan cilexetil)
    Mylan Pharmaceuticals Inc.
    Usage: Candesartan cilexetil is indicated for treating hypertension in adults and children (ages 1-17) to lower blood pressure, reducing cardiovascular event risks. Additionally, it treats heart failure (NYHA class II-IV) in adults with left ventricular dysfunction, lowering cardiovascular death and hospitalizations, and can be combined with ACE inhibitors.

  • Carvedilol (carvedilol)

    (carvedilol)
    Mylan Pharmaceuticals Inc.
    Usage: Carvedilol is indicated for treating mild-to-severe chronic heart failure, reducing cardiovascular mortality in stable post-myocardial infarction patients with left ventricular dysfunction, and managing essential hypertension, either alone or with other antihypertensive agents.

  • Dabigatran etexilate (dabigatran etexilate)

    (Dabigatran Etexilate)
    Mylan Pharmaceuticals Inc.
    Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating and preventing deep vein thrombosis and pulmonary embolism in adults and pediatric patients aged 8-17, and preventing recurrence of venous thromboembolic events.

  • Dapsone (dapsone)

    (Dapsone)
    Mylan Pharmaceuticals Inc.
    Usage: Dapsone gel, 7.5%, is indicated for the topical treatment of acne vulgaris in patients aged 9 years and older.

  • Doxepin hydrochloride (doxepin hydrochloride)

    (Doxepin Hydrochloride)
    Mylan Pharmaceuticals Inc.
    Usage: Doxepin hydrochloride tablets are indicated for treating insomnia, specifically for difficulties with maintaining sleep. Efficacy was supported by clinical trials lasting up to three months.

  • Doxepin hydrochloride (doxepin hydrochloride)

    (doxepin hydrochloride)
    Mylan Pharmaceuticals Inc.
    Usage: Doxepin Hydrochloride Capsules are indicated for treating depression and/or anxiety in psychoneurotic patients, those with alcoholism, organic disease, and psychotic depressive disorders. The drug effectively addresses symptoms such as anxiety, tension, and sleep disturbances. Not recommended for children under 12.